Literature DB >> 35277805

Catheter Ablation vs. Antiarrhythmic Drugs as Therapy for Paroxysmal Atrial Fibrillation.

Jocelyn Carter1, Taisuke Sato2, Harry Burke3.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2022        PMID： 35277805      PMCID： PMC9086011          DOI： 10.1007/s11606-021-07211-8

Source DB:  PubMed          Journal:  J Gen Intern Med        ISSN： 0884-8734            Impact factor:   6.473


× No keyword cloud information.
  4 in total

1.  A comparison of rate control and rhythm control in patients with atrial fibrillation.

Authors:  D G Wyse; A L Waldo; J P DiMarco; M J Domanski; Y Rosenberg; E B Schron; J C Kellen; H L Greene; M C Mickel; J E Dalquist; S D Corley
Journal:  N Engl J Med       Date:  2002-12-05       Impact factor: 91.245

2.  Assessment of Catheter Ablation or Antiarrhythmic Drugs for First-line Therapy of Atrial Fibrillation: A Meta-analysis of Randomized Clinical Trials.

Authors:  Mohit K Turagam; Daniel Musikantow; William Whang; Jacob S Koruth; Marc A Miller; Marie-Noelle Langan; Aamir Sofi; Subbarao Choudry; Srinivas R Dukkipati; Vivek Y Reddy
Journal:  JAMA Cardiol       Date:  2021-06-01       Impact factor: 14.676

3.  Catheter ablation of atrial fibrillation in elderly population.

Authors:  Josef Kautzner; Petr Peichl; Marek Sramko; Robert Cihak; Bashar Aldhoon; Dan Wichterle
Journal:  J Geriatr Cardiol       Date:  2017-09       Impact factor: 3.327

4.  Outcomes and Resource Utilization Associated With Readmissions After Atrial Fibrillation Hospitalizations.

Authors:  Byomesh Tripathi; Varunsiri Atti; Varun Kumar; Vamsidhar Naraparaju; Purnima Sharma; Shilpkumar Arora; Ewelina Wojtaszek; Radha Gopalan; Konstantinos C Siontis; Bernard J Gersh; Abhishek Deshmukh
Journal:  J Am Heart Assoc       Date:  2019-09-19       Impact factor: 5.501
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.